The Impact of Socioeconomic Status on Hypertension and Diabetes Management
Abstract
Hypertension and diabetes are prevalent chronic diseases with significant global health implications. Socioeconomic status (SES)— encompassing income, education, and occupation—plays a crucial role in the management and outcomes of these conditions. Individuals from lower SES backgrounds often experience worse health outcomes due to limited access to healthcare, poor health literacy, financial constraints, and environmental stressors. This article explores the complex relationship between SES and the management of hypertension and diabetes, highlighting the disparities in prevalence, access to care, and adherence to treatment regimens. Key factors such as limited access to medications, healthcare professionals, and lifestyle interventions exacerbate the challenges faced by lower SES populations, leading to poorer disease control and increased complications. Moreover, the intersectionality of race, ethnicity, and gender further intensifies these disparities. Addressing these issues requires comprehensive policy interventions aimed at expanding healthcare access, improving health literacy, and tackling the social determinants of health. Ultimately, reducing SES-related health disparities is essential for improving the management and outcomes of hypertension and diabetes, particularly in disadvantaged population
How to cite this article:
Shah R, Upadhyay A.The Impact of
Socioeconomic Status on Hypertension and
Diabetes Management. Ind J Adv Nurs Care
Health Stud. 2025;1(1):10-14.
References
Safford MM, May HT, Brown TM, et al. Hypertension management in the United States: time to move beyond blood pressure targets. Circulation. 2015;131(6): 561569. doi:10.1161/CIRCULATIONAHA.114.013221.
Bleich SN, Jarlenski MP, Bell CN, et al. Health inequalities: trends, progress, and policy. Annu Rev Public Health. 2012;33:7-25. doi:10.1146/annurev publhealth-031811-124600.
Stevens PE, O’Seaghdha CM, Taal MW. Management of diabetes and hypertension in the context of socioeconomic disadvantage. Lancet Diabetes Endocrinol. 2016;4(6):478-487. doi:10.1016/S2213
(16)30046-X.